Epizyme (EPZM) Tops Q4 EPS by 19c

Epizyme (NASDAQ: EPZM) reported Q4 EPS of ($0.29), $0.19 better than the analyst estimate of ($0.48). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $8 million.

For earnings history and earnings-related data on Epizyme (EPZM) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• Smith-Midland Corporation (SMID) Tops Q2 EPS by 26c
• BWS Financial Downgrades Inter Parfums (IPAR) to Sell